Search

Your search keyword '"Vidaud M"' showing total 7 results
Start Over Author "Vidaud M" Database Gale General OneFile
7 results on '"Vidaud M"'

1. Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4

Author

Moucari, R., Ripault, M.-P., Martinot-Peignoux, M., Voitot, H., Cardoso, A.-C., Stern, C., Boyer, N., Maylin, S., Nicolas-Chanoine, M.-H., Vidaud, M., Valla, D., Bedossa, P., and Marcellin, P.

Subjects
Hepatitis C -- Care and treatment, Hepatitis C -- Patient outcomes, Hepatitis C -- Models, Hepatitis C -- Research, Insulin resistance -- Research, Peginterferon alfa-2a -- Dosage and administration, Peginterferon alfa-2a -- Research, Peginterferon alfa-2b -- Dosage and administration, Peginterferon alfa-2b -- Research, Ribavirin -- Dosage and administration, Ribavirin -- Research, Health
Published
2009

2. Gene expression and hepatitis C virus infection

Author

Asselah, T., Bieche, I., Sabbagh, A., Bedossa, P., Moreau, R., Valla, D., Vidaud, M., and Marcellin, P.

Subjects
Hepatitis C -- Development and progression, Hepatitis C -- Genetic aspects, Hepatitis C -- Care and treatment, Gene expression -- Analysis, Cystic fibrosis -- Genetic aspects, Health
Published
2009

3. Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C

Author

Asselah, T., Bieche, I., Narguet, S., Sabbagh, A., Laurendeau, I., Ripault, M.-P., Boyer, M., Martinot-Peignoux, M., Valla, D., Vidaud, M., and Marcellin, P.

Subjects
Hepatitis C -- Care and treatment, Hepatitis C -- Genetic aspects, Peginterferon alfa-2a -- Dosage and administration, Ribavirin -- Dosage and administration, Drug therapy, Combination -- Patient outcomes, Drug therapy, Combination -- Research, Gene expression -- Analysis, Immune response -- Research, Health
Published
2008

4. Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease

Author

Paradis, V., Bieche, I., Dargere, D., Cazals-Hatem, D., Laurendeau, I., Saada, V., Belghiti, J., Bezeaud, A., Vidaud, M., Bedossa, P., and Valla, D.-C.

Subjects
Hepatic vein thrombosis -- Genetic aspects, Hepatic vein thrombosis -- Development and progression, Gene expression -- Analysis, Reverse transcriptase -- Analysis, Polymerase chain reaction -- Usage, Health
Published
2005

5. Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C

Author

Asselah, T., Boyer, N., Guimont, M-C., Cazals-Hatem, D., Tubach, F., Nahon, K., Daikha, H., Vidaud, D., Martinot, M., Vidaud, M., Degott, C., Valla, D., and Marcellin, P.

Subjects
Influence, Physiological aspects, Research, Inflammation -- Influence -- Physiological aspects -- Research, Hepatitis C -- Physiological aspects -- Research, Fibrosis -- Physiological aspects -- Research, Viral hepatitis -- Research, Statistics (Data) -- Physiological aspects -- Research, Hepatitis, Viral -- Research, Statistics -- Physiological aspects -- Research
Abstract

Gut 2003;52: 1638-1643 Background: In chronic hepatitis C, it has been suggested that steatosis could accelerate progression of fibrosis. However, results of the few published studies are controversial. Aim: To [...]

Published
2003

6. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype

Author

Pasmant, E., Sabbagh, A., Hanna, N., Masliah-Planchon, J., Jolly, E., Goussard, P., Ballerini, P., Cartault, F., Barbarot, S., Landman-Parker, J., Soufir, N., Parfait, B., Vidaud, M., Wolkenstein, P., Vidaud, D., and France, R.N.F.

Subjects
Neurofibromatosis -- Research, Neurofibromatosis -- Genetic aspects, Phenotype -- Research, Phenotype -- Physiological aspects, Gene mutations -- Research, Health
Published
2009

7. Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapy. (Case Report)

Author

Asselah, T., Vidaud, D., Doloy, A., Boyer, N., Martinot, M., Vidaud, M., Valla, D., and Marcellin, P.

Subjects
Identification and classification, Complications and side effects, Physiological aspects, Case studies, Dosage and administration, Recurrence (Disease) -- Physiological aspects -- Case studies -- Complications and side effects, Hepatitis C -- Case studies -- Complications and side effects -- Physiological aspects, Hepatitis C virus -- Identification and classification -- Case studies -- Physiological aspects, Interferon -- Dosage and administration -- Physiological aspects -- Case studies, Diseases -- Relapse
Abstract

The prevalence of antibodies against hepatitis C virus (anti-HCV) among intravenous drug users (IVDU) has consistently been very high. Cross challenge studies in chimpanzees provide evidence that reinfection with different [...]

Published
2003

Catalog

Books, media, physical & digital resources
See catalog results